France2030 - Phost'in

08/09/2025

Press release

Biotech, Clinical, Clinical Development, Drug Discovery, Fibrosis, France2030, Funding, Grant, MASH, NASH, Small molcules

Phost’in Therapeutics Is Awarded €3.2m Through The France 2030 Investment Plan To Pioneer N-Glycosylation Inhibitors Against Chronic Fibrosis

Montpellier, France – August 2023, 25th